Online Medical Treatments Canada | JOYEE Care
Online Medical Treatments in Canada | Licensed Telehealth Care
JOYEE provides confidential online consultations, clinical assessments, and prescription fulfillment across Canada for four core conditions: medical weight loss (GLP-1 therapies), male pattern hair loss, erectile dysfunction, and prescription dermatology. Following an asynchronous virtual medical evaluation by a licensed Canadian prescriber, approved treatments are dispensed by accredited partner pharmacies and delivered directly in discreet, unmarked packaging across all Canadian provinces.
Clinical Review & Medical Oversight
- Clinical Reviewer: Dr. Sarah Tremblay, MD, CCFP, CPSO #78421
- Last Medically Reviewed: October 16, 2026
- Regulatory Compliance: Health Canada Drug Identification Number (DIN) standards, Canadian Urological Association (CUA) guidelines, and Canadian Dermatology Association (CDA) guidelines.
Our Four Core Treatment Categories
| Category | Primary Treatments / Active Ingredients | Clinical Indication | Dispensing & Starting Cost |
|---|---|---|---|
| Medical Weight Loss | Generic Semaglutide (Authorized), Tirzepatide, Brand Wegovy®/Ozempic® | Adult BMI ≥ 30 or ≥ 27 with weight-related comorbidities | Cold-chain shipping; from $299/mo |
| Hair Restoration | Finasteride (1 mg oral), Topical Minoxidil + Finasteride, Oral Minoxidil | Androgenetic alopecia (male pattern hair loss) | Discrete home delivery; from $40/mo ($120 billed quarterly) |
| Erectile Dysfunction | Generic Tadalafil (daily/on-demand), Generic Sildenafil | Vascular, neurogenic, or psychogenic erectile difficulties | Discrete home delivery; from $3.00/dose |
| Prescription Skincare | Tretinoin (0.025%–0.1%), Clindamycin, Azelaic Acid, Spironolactone | Persistent adult acne, hormonal cystic breakouts, photoaging | Discrete home delivery; from $45/mo |
1. Medical Weight Loss
Obesity is a chronic metabolic disease governed by complex neuroendocrine signaling rather than simple willpower. For eligible patients, licensed Canadian healthcare providers on JOYEE prescribe GLP-1 (glucagon-like peptide-1) receptor agonists and dual GLP-1/GIP agonists:
- Semaglutide: Mimics endogenous GLP-1 to enhance satiety, delay gastric emptying, and suppress central appetite cues. Clinical trials (STEP-1) demonstrated average reductions of ~15% body weight over 68 weeks alongside lifestyle intervention.
- Tirzepatide: Dual receptor agonist providing powerful metabolic glucose regulation and appetite suppression.
2. Hair Restoration and Regrowth
Male Pattern Baldness (Androgenetic Alopecia) is driven by scalp sensitivity to Dihydrotestosterone (DHT), which miniaturizes vulnerable follicles on the crown and temples:
- Oral Finasteride (1 mg): Inhibits type II 5-alpha reductase, reducing scalp and serum DHT by approximately 70% to stop miniaturization and halt progression in over 85% of men.
- Topical / Oral Minoxidil: Acts as a potassium-channel opener and vasodilator, prolonging the anagen (growth) phase of follicles to increase shaft diameter and hair density.
3. Erectile Dysfunction (ED)
According to Canadian Urological Association (CUA) clinical practice guidelines (Bella et al., CUAJ 2015), erectile dysfunction affects over 40% of Canadian men over age 40. Primarily driven by endothelial and vascular health, ED is treated first-line with PDE5 inhibitors:
- Tadalafil (active ingredient in Cialis®): Sustained 36-hour therapeutic window; available as a 5 mg daily dose for spontaneous intimacy or 10 mg/20 mg on-demand.
- Sildenafil (active ingredient in Viagra®): On-demand dosing taken 30–60 minutes prior to intercourse with a 4–6 hour clinical duration.
- Contraindication: Strictly contraindicated with nitrates (such as nitroglycerin) or guanylate cyclase stimulators due to risk of fatal hypotension.
4. Prescription Dermatology and Skincare
Over-the-counter cosmetics are legally capped at low bioavailable strengths. Clinical dermatological treatments prescribe therapeutic active ingredients:
- Tretinoin: Pure all-trans retinoic acid accelerates cellular turnover, prevents microcomedone formation, and stimulates dermal neocollagenesis.
- Clindamycin + Benzoyl Peroxide: Eradicates Cutibacterium acnes within the follicular lumen; benzoyl peroxide reduces the risk of bacterial resistance.
- Oral Spironolactone: Prescribed under Canadian Dermatology Association guidance to block androgenic sebaceous hypersecretion in adult female hormonal acne.
The Clinical Care Process at JOYEE
- Confidential Virtual Intake: Select your treatment category and complete a comprehensive health questionnaire covering medical history, symptoms, allergies, and concurrent medications in 5–10 minutes.
- Licensed Canadian Provider Review: A Canadian-licensed physician or nurse practitioner assesses your clinical presentation, confirms eligibility, and issues a prescription when clinically indicated.
- Dispensed by Accredited Canadian Pharmacy: Prescriptions are dispensed and filled exclusively by accredited partner pharmacies regulated by provincial bodies (such as OCP in Ontario).
- Discreet Doorstep Delivery: Packages arrive in unmarked, plain packaging with zero external indication of contents or medical services.
- Ongoing Clinical Follow-Up: Continuous access to secure messaging with your provider for dose titration, side-effect questions, or prescription renewals.
Frequently Asked Questions (FAQs)
Are the prescribers licensed in Canada?
Yes. All healthcare providers on JOYEE are fully licensed Canadian physicians or nurse practitioners in good standing with their respective provincial regulatory colleges (e.g., CPSO).
Can I claim treatments through Canadian private insurance?
Yes. While provincial health plans do not cover private telehealth consultations, many Canadian workplace extended health plans cover prescription medications with a Health Canada Drug Identification Number (DIN). Official pharmacy receipts are provided with every delivery.
Clinical References
- Bella AJ, Lee JC, Carrier S, et al. 2015 CUA Practice guidelines for erectile dysfunction. Can Urol Assoc J. 2015;9(1-2):23-29.
- Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). N Engl J Med. 2021;384(11):989-1002.
- Kaufman KD, Olsen EA, Whiting D, et al. Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol. 1998;39(4 Pt 1):578-589.
Disclaimer: Content on this page is for informational purposes only and does not substitute professional medical advice. Always consult a licensed Canadian healthcare provider before starting any new medication.